1. Barwasni capacity expansion - The Sonipat formulation plant (₹70 cr capex) and dry flowable unit (₹14 cr) are set to start in Q1 FY27, lifting capacity \~50%; the broader Barwasni expansion, with ₹76 cr spent and ₹8-10 cr more planned, should be operational by end FY27. Management targets ₹1,500-1,600 cr revenue in 2-3 years versus \~₹1,100-1,200 cr peak at current capacity - the capex is already largely funded and removes the main capacity bottleneck.
2. Backward integration into technicals - Captive consumption of active ingredients rose to \~34% in Q1 FY27 from \~22% a year earlier, with China cutting export incentives for agri-chemical makers. Each step up in self-manufacture replaces imported technicals with in-house production, directly lifting gross margin on the \~85% of revenue that is crop protection.
3. AGPL multi-brand rollout - The Mascot Giraffe subsidiary hit ₹54 cr gross sales in 9M FY26, its first full year, and contributed 13% of total revenue in Q3 FY26; it adds Chhattisgarh and Odisha in FY27 after adding \~1,300-1,400 channel partners last year. This is a second domestic brand riding spare capacity, with EBITDA margin already at high single digits on operating leverage.
4. Export registrations & new markets - The company holds 189 registrations globally, with more than 120 valid and 10+ under renewal; FY26 added Taiwan, Sri Lanka and parts of Africa, with initial orders of ₹4-5 crore from Venezuela, Taiwan and Sudan. Each registration is a license to sell in a new market - Saudi Arabia already has five technical registrations with more in the pipeline - and export order margins run 7-18%.
5. Specialty product launches - Three new specialty products are planned for FY27 - a nutrient, a herbicide (Fomesafen plus Quizalofop) and a fungicide launching in August after a patent expiry; two are already in market. Specialty products launched in the last three years contributed \~16% of FY26 revenue, and the pipeline targets 10-15 new products annually.
6. Biologicals & plant nutrition mix shift - Biologicals carry \~70% gross margin and plant nutrients \~52%; their combined share of brand sales doubled to 22% in Q1 FY27 from 11% a year earlier. Shifting mix toward these segments lifts blended margin even at flat volumes, and the government's Fertiliser Control Order framework now covers all the company's biological products.